Social network
  • Visit We R Hope page

    We R Hope by Sanofi

  • Fighting dengue ferver

    Fighting dengue ferver

  • Meet Anne-Olivier Bandini: R&D Team Leader, France

  • Isabelle, Type 1 diabetes, France

    Isabelle, Type 1 diabetes, France

    Tools content (print, share, increase/decrease text size):


    Networks For Hope

    Collaboration across regions and disciplines is the only way to deliver the best and most innovative solutions that patients are hoping for.

    Accelerating innovation through partnerships

    No single institution, company, university, country or government can solve global health issues by itself. To understand the complexity of human diseases, it is essential to be part of the broader scientific and medical community.

    Our way of addressing this challenge is to work locally with all those who can help us apply the wealth of new knowledge and cutting-edge technologies that are currently reshaping the nature of biopharmaceutical research.

    This means that in each of our locations, in North America, France, Germany and Asia-Pacific, we work in networks with patients and patients associations, hospitals, biotech companies, research institutes, and many others. This allows us to tap into the best science and talent available in research around the world. Through this approach, our objective is to significantly reduce the time it takes to translate laboratory discoveries into effective patient treatments.


    A closer look at our Boston R&D Hub

    Our more than 1,500 employees in the Boston area are focusing their efforts on research in key areas, with major medical needs, such as rare diseases, multiple sclerosis, vaccines and oncology. Through external relationships with some of the world’s best universities, hospitals and medical institutions in the region, our teams are dedicated to finding tomorrow’s treatments with the potential to significantly improve patients’ lives.

    As part of the Sanofi Boston R&D Hub, Sanofi Genzyme is working to deliver scientific advancements that will have a significant impact on the unmet needs of people living with multiple sclerosis and rare diseases. The Sanofi-Genzyme R&D Center in Framingham has a robust research effort in the area of immunologic and neurologic diseases, expanding our research into neuropathic lysosomal storage disorders (LSDs), lupus and Huntington’s disease. We also have one of the industry’s longest standing and largest research programs in the field of gene therapy, and currently have clinical trials in Parkinson’s disease and age-related macular degeneration.


    Jim BurnsR&D has a key role in innovation, but we cannot do it alone. The Boston Hub brings together expertise from across the Sanofi organization in close proximity to great academic institutions and hospitals, enabling us to capitalize on the cross-fertilization of ideas within Boston’s entrepreneurial environment.

    Jim Burns, Head of the Boston R&D Hub

    Right area:

    Partners: learn more on our approach
    Innovating in networks

    © Sanofi 2004-2017 - All rights reserved - Update: November 28, 2016

    • Site complies with W3C WCAG 2.0 (new window, in english)